Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS study

Citation
E. Delgado et al., Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: A UNAIDS study, AIDS RES H, 17(8), 2001, pp. 753-758
Citations number
23
Categorie Soggetti
Immunology
Journal title
AIDS RESEARCH AND HUMAN RETROVIRUSES
ISSN journal
08892229 → ACNP
Volume
17
Issue
8
Year of publication
2001
Pages
753 - 758
Database
ISI
SICI code
0889-2229(20010520)17:8<753:AOHT1P>2.0.ZU;2-Q
Abstract
We report the first study on prevalence of antiretroviral drug-associated r esistance mutations in Venezuela, Protease and reverse transcriptase (RT) c oding regions were analyzed in DNA samples obtained from 100 HIV-1-infected individuals. Primary resistance mutations to RT inhibitors were identified in 26% of patients treated with these drugs, Transmission of HIV-1-resista nt strains was detected in a drug-naive patient (3%), Primary resistance mu tations to protease inhibitors (PIs) were present in 9% of the 44 PI-treate d patients and in 1 PI-naive individual. Phylogenetic analysis of these sam ples has resulted in the most extensive survey, to date, of HIV-1 genetic f orms circulating in Venezuela, Ninety-nine samples clustered with subtype B , and 1 individual harbored the first B/F recombinant virus reported in Ven ezuela, with protease clustering with subtype F and RT with subtype B, In a ddition, this isolate had a new insertion (Glu-34 duplication) in the prote ase gene.